Heather Preston's Net Worth
-$670 Thousand
Who is Heather Preston?
Heather Preston does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ALDER BIOPHARMACEUTICALS INC, Fusion Pharmaceuticals Inc., ALBIREO PHARMA, INC., Karuna Therapeutics, Inc., Entasis Therapeutics Holdings Inc., OTONOMY, INC., Akouos, Inc., and Aligos Therapeutics, Inc..
SEC CIK
Heather Preston's CIK is 0001606826
Past Insider Trading and Trends
2020 was Heather Preston's most active year for acquiring shares with 13 total transactions. Heather Preston's most active month to acquire stocks was the month of May. 2019 was Heather Preston's most active year for disposing of shares, totalling 3 transactions. Heather Preston's most active month to dispose stocks was the month of September. 2020 saw Heather Preston paying a total of $657,463.79 for 62,820 shares, this is the most they've acquired in one year. In 2022 Heather Preston cashed out on 21,882 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALDER BIOPHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Fusion Pharmaceuticals Inc. (FUSN) No price found
InvestorHeather Preston owns 8,823 units of Common Stock. In the year 2020 Heather Preston filed a total of 6 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
∞
| 8.82K |
$17.00 | $149,991.00 | 8.82K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ALBIREO PHARMA, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Karuna Therapeutics, Inc. (KRTX) No price found
InvestorHeather Preston owns 6,556 units of Common Stock. In the year 2019 Heather Preston filed a total of 11 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.89% | 184 |
—
|
—
| 6.56K |
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| +9.86% | 572 |
—
|
—
| 6.37K |
Mar 8
| |||
Form 4
| +6.42% | 350 |
$72.36 | $25,326.00 | 5.8K |
Sep 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
| +127.08% | 3.05K |
$74.43 | $226,997.79 | 5.45K |
Mar 10 - Mar 12
| |||
Form 4
| +48.88% | 788 |
$70.50 | $55,554.00 | 2.4K |
Jan 9
| |||
Form 4
| +771.35% | 1.43K |
$69.80 | $99,601.00 | 1.61K |
Jan 3
| |||
Form 4
|
∞
| 185 |
$70.00 | $12,950.00 | 185 |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Entasis Therapeutics Holdings Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
| +300.87% | 1.16M |
$15.00 |
—
| 1.54M |
Sep 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |